Book Description:
Cholesterol is a soft, waxy substance found among the lipids (fats) in the bloodstream and in all the body's cells. It's an important part of a healthy body because it's used to form cell membranes, some hormones and is needed for other functions. But a high level of cholesterol in the blood — hypercholesterolemia — is a major risk factor for coronary heart disease, which leads to heart attack. Cholesterol and other fats can't dissolve in the blood. They have to be transported to and from the cells by special carriers called lipoproteins. There are several kinds, but the key ones are low-density lipoprotein (LDL) and high-density lipoprotein (HDL) Low-density lipoprotein is the major cholesterol carrier in the blood. If too much LDL cholesterol circulates in the blood, it can slowly build up in the walls of the arteries feeding the heart and brain. Together with other substances it can form plaque, a thick, hard deposit that can clog those arteries. This field is alive with exciting new research in all areas including frontal advances in the areas of managing cholesterol as well as cholesterol lowering drugs. This new book focuses on cholesterol in atherosclerosis and coronary heart disease.

Table of Contents:
Chapter Availability

Individual chapters are available for $25 each by sending an email to novascience@earthlink.net. Nova will provide the chapter for your easy downloading or send it as an email attachment if you prefer.

Preface; The Emerging Role of High-Density Lipoprotein in the Management of Cardiovascular Disease (Peter P. Toth, University of Illinois School of Medicine)pp.1-28; Oxidized LDL: Role in Cardiovascular Risk and Disease (Paul Holvoet, University of Leuven, Belgium)pp.29-44; Effects of Therapy with LDL Apheresis in Patients with Familial Hypercholestrolemia – the Dresden Experience (U. Julius and C. Namokel, Universitätsklinikum Carl Gustav Carus Dresden, Germany)pp.45-62; HDL Cholesterol and CETP Inhibitors (Hisashi Shinkai, Central Pharmaceutical Research Institute, JT Inc.)pp.63-78; Differential Response of High Density Lipoprotein Cholesterol to Hypolipidemic Treatment (Genovefa D. Kolovou, Onassis Cardiac Surgery Center, Athens, Greece)pp.79-102; Hyperlipidemia and Immunosuppressive Therapy – Pitfalls of Post Transplantation Management (Marius Berman, Tel Aviv University, Israel)pp.103-130; Postprandial Lipemia and Atherosclerosis: Exercise and Omega 3 Fatty Acids: the Non Pharmaceutical Interventions (John Q. Zhang, University of Texas at San Antonio)pp.131-156; Lipid-lowering Drugs. Pharmacoepidemiological Studies of Prescription Patterns in General Practice (John Larsen, University of Southern Denmark)pp.157-186; The Cholesterol Lowering Effect of Plant Sterols (Elizabeth J. Brink and Henk F.J. Hendriks, TNO Nutrition and Food Research, The Netherlands)pp.187-214; Homecysteine and Cardiovascular Risk (Johann Auer et al., General Hospital Wels, Austria)pp.215-232; Infection, Dyslipidemia, and Early Atherosclerosis: Interaction and Causation (Petru Liuba, University Hospital Lund, Sweden)pp.233-254; Index.